JACNX
Janus Henderson Contrarian-D
Introduction to Janus Henderson Contrarian-D
The Janus Henderson Contrarian-D (JACNX) is a mutual fund designed to achieve long-term growth of capital by investing primarily in midcap equity securities. With a focus on attractively valued companies, the fund aims to capitalize on potential growth opportunities within the midcap sector. Managed by Janus Henderson, a reputable name in the investment industry, JACNX offers investors a strategic approach to growth investing. The fund’s objective aligns with investors seeking capital appreciation through a diversified portfolio of midcap stocks, making it an appealing choice for those looking to enhance their growth potential.
At A Glance
Executive Summary
JACNX offers a compelling growth strategy with a 45.53% 1-year return, focusing on attractively valued midcap equities and a competitive 0.76% expense ratio.
Strong 1-year return of 45.53%. Focus on attractively valued midcap equities. Competitive expense ratio of 0.76%.
Higher beta of 1.16 indicates more volatility. Lower yield of 0.43% may not suit income-focused investors. Max drawdown of -8.8% could concern risk-averse investors.
Impressive Recent Performance
JACNX has demonstrated remarkable performance over the past year, boasting a 1-year return of 45.53%, significantly outperforming its benchmark, the S&P 500 Total Return Index, which returned 37.62% over the same period. This impressive performance highlights the fund’s ability to capitalize on market opportunities and deliver substantial returns to its investors. The fund’s strong performance can be attributed to its strategic selection of midcap equities, which have benefited from favorable market conditions and growth trends. Investors seeking high returns in the midcap space may find JACNX’s recent performance particularly attractive.
Strategic Portfolio Composition
The portfolio composition of JACNX is strategically designed to maximize growth potential while managing risk. The fund allocates 95.52% of its assets to U.S. equities, with a significant focus on the technology (18.44%) and healthcare (23.65%) sectors. This allocation reflects the fund’s emphasis on sectors with strong growth prospects and innovation potential. Additionally, the fund’s top holdings, including companies like Caesars Entertainment Inc and Oracle Corp, showcase its commitment to investing in attractively valued companies with robust growth potential. This strategic composition positions JACNX to capitalize on emerging trends and opportunities within the midcap market.
Risk and Volatility Considerations
Investors should be aware of the risk and volatility associated with JACNX. The fund has a beta of 1.16, indicating a higher level of volatility compared to the benchmark. While this suggests potential for higher returns, it also implies increased risk, which may not be suitable for all investors. The fund’s standard deviation of 4.79% and a max drawdown of -8.8% further highlight the potential for fluctuations in value. However, the fund’s alpha of 7.87% suggests that it has historically outperformed its benchmark on a risk-adjusted basis, providing a potential reward for investors willing to accept the associated risks.
Competitive Expense Ratio
JACNX offers a competitive expense ratio of 0.76%, which is relatively low compared to similar funds in the midcap growth category. This cost efficiency allows investors to retain more of their returns, enhancing the overall value of their investment. In comparison, similar funds such as Neuberger Berman MidCap Growth-Inv (NMANX) and Pioneer Select MidCap Growth-A (PGOFX) have higher expense ratios, making JACNX an attractive option for cost-conscious investors. The fund’s ability to deliver strong performance while maintaining a competitive expense structure underscores its appeal to growth-focused investors.
Comparison with Similar Funds
When compared to similar funds, JACNX stands out for its strong performance and strategic focus on attractively valued midcap equities. While funds like Fidelity Growth Strategies (FDEGX) and Virtus Silvant MidCap Growth-I (DRMCX) also offer competitive returns, JACNX’s 1-year return of 45.53% is among the highest in its category. Additionally, its expense ratio of 0.76% is lower than many of its peers, providing a cost-effective option for investors. The fund’s unique approach to selecting undervalued midcap stocks sets it apart from competitors, making it a compelling choice for those seeking growth opportunities in this segment.
Investor Suitability and Considerations
JACNX is well-suited for investors seeking long-term capital appreciation through exposure to midcap equities. Its focus on attractively valued companies with growth potential makes it an ideal choice for growth-oriented investors. However, the fund’s higher beta and associated volatility may not be suitable for risk-averse investors or those seeking stable income. The fund’s relatively low yield of 0.43% may also deter income-focused investors. Overall, JACNX offers a compelling growth strategy for investors willing to accept higher risk in exchange for the potential of substantial returns.
Conclusion: A Compelling Growth Opportunity
In conclusion, Janus Henderson Contrarian-D (JACNX) presents a compelling opportunity for investors seeking growth in the midcap sector. With its strong recent performance, strategic portfolio composition, and competitive expense ratio, the fund stands out as a top choice for growth-oriented investors. While it carries higher risk and volatility, its potential for substantial returns makes it an attractive option for those willing to embrace the associated risks. Investors looking to enhance their portfolio with a focus on midcap equities and long-term capital appreciation should consider JACNX as a valuable addition to their investment strategy.
Similar Securities
BSDAX: BlackRock Small/MidCap Growth Fund | High-Growth U.S. Equities
BSDAX offers exposure to high-growth U.S. small/mid-cap stocks with a focus on above-average earnings potential, despite higher volatility.
MASPX: BlackRock Advantage Small/MidCap-Inst | High Growth Potential
MASPX offers a competitive 38.71% 1-year return with a low 0.48% expense ratio, focusing on small to mid-cap equities for growth.
JSVSX: Janus Henderson Small/MidCap Value-S | Growth Potential in Undervalued MidCaps
JSVSX offers growth through undervalued midcap stocks with a strong 1-year return of 43.42%, outperforming its benchmark.
JAENX: Janus Henderson Enterprise-T | MidCap Growth Fund Analysis
JAENX focuses on mid-cap growth with a 0.91% expense ratio, offering a 34.28% 1-year return, emphasizing technology and healthcare sectors.
PMEGX: TRPrice Inst MidCap Equity Growth-Inst | Mid-Cap Growth Investment
PMEGX offers mid-cap growth with a 0.61% expense ratio, focusing on stocks with high earnings potential. Strong 1-year return of 29.07%.
Futher Reading
https://finance.yahoo.com/quote/JACNX/”>Yahoo: Janus Henderson Contrarian-D
Disclaimer: The information provided on this website is for informational purposes only and should not be construed as financial, investment, or other professional advice. PeepFinance does not endorse or recommend any specific securities, investments, or strategies. The opinions expressed are solely those of the authors and are not intended to be used as the basis for any investment decisions. All investments carry risks, and readers are encouraged to conduct their own research or consult with a financial professional before making any financial decisions. PeepFinance and its authors are not responsible for any losses or damages arising from the use of this information.